Meet the Experts: Managing Life-Threatening Bleeding in Anticoagulated Patients in the Emergency Department

Meet the Experts: Managing Life-Threatening Bleeding in Anticoagulated Patients in the Emergency Department

This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.

Read More

Identifying Anticoagulated Patients in the ED and ICU - Who Should Receive Repletion or Reversal Therapy for Life-Threatening GI Bleeding?

Identifying Anticoagulated Patients in the ED and ICU - Who Should Receive Repletion or Reversal Therapy for Life-Threatening GI Bleeding?

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding or appropriately employing emergent options to manage major bleeding.

Read More

Should 4F-PCCs Ever be Used In the Resuscitation of the Patient Treated with a Factor Xa Inhibitor?

Should 4F-PCCs Ever be Used In the Resuscitation of the Patient Treated with a Factor Xa Inhibitor?

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over the last 12-18 months, nationally recognized guidelines have provided clear direction on how best to manage these types of major bleeding events.

Read More

Should You Ever Wait to Treat Intracranial Hemorrhage in the Anticoagulated Patient?

Should You Ever Wait to Treat Intracranial Hemorrhage in the Anticoagulated Patient?

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies.

Read More

Dual Antiplatelet Therapy for Small Acute Ischemic Strokes (NINDS Score ≤ 5 and TIA)

Dual Antiplatelet Therapy for Small Acute Ischemic Strokes (NINDS Score ≤ 5 and TIA)

The impact of the ever-changing COVID-19 pandemic is creating a rapidly evolving clinical environment for healthcare providers (HCPs). HCPs are challenged to keep up with the most current clinical information, while constantly evolving their approaches to the management of patients with acute ischemic stroke or transient ischemic attacks (TIA). As a result, innovative approaches are required to educate HCPs on how they can make a positive impact on patient care and improve clinical outcomes in the new COVID-19 world, especially as it relates to emergency medicine.

Read More

Repletion vs. Reversal - Understanding Differences in Treating Hemorrhages in Patients Receiving Anticoagulants

Repletion vs. Reversal - Understanding Differences in Treating Hemorrhages in Patients Receiving Anticoagulants

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies.

Read More

Management of Life-Threatening Bleeding in the Anticoagulated Patient in the Emergency Department

Management of Life-Threatening Bleeding in the Anticoagulated Patient in the Emergency Department

The current approach and disease indications for treatment with anticoagulants such as coumadin, Factor IIa, and Factor Xa inhibitors are particularly relevant. This program is highlighted by the presentation of cases managed by experts in emergency medicine, critical care medicine, hospital medicine, and trauma surgery.

Read More

The Bleeding Patient in the Emergency Department, Evidence-Based Approaches

The Bleeding Patient in the Emergency Department, Evidence-Based Approaches

As the utilization of direct oral anticoagulants (DOACs) increase, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding.

Read More